Weltman, Martin
Beth Israel Deaconess Medical Center · Nepean Hospital · Amsterdam UMC Location University of Amsterdam · University of Amsterdam
7 papers on CoChatORCID 0000-0002-1677-7653
Most cited papers
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,122
- Verified
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study
Koloski, N. A., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., & Talley, N. J. (2012) · Gut
Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments
Cited by 611
- Verified
Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 482
- Verified
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial
Mayo, M. J., Wigg, A. J., Leggett, B. A., Arnold, H., Thompson, A. J., Weltman, M., Carey, E. J., Muir, A. J., Ling, L., Rossi, S. J., et al. (2018) · Hepatology Communications
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 125
- Verified
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Mak, L.-Y., Gane, E., Schwabe, C., Yoon, K. T., Heo, J., Scott, R., Lee, J.-H., Lee, J. I., Kweon, Y. O., Weltman, M., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentRNA Interference and Gene Delivery
Cited by 98
- Verified
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones, D. E. J., Beuers, U., Bonder, A., Carbone, M., Culver, E., Dyson, J., Gish, R. G., Hansen, B. E., Hirschfield, G., Jones, R., et al. (2024) · Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free